These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21188533)

  • 1. An association between DNA repair gene polymorphisms and survival in patients with resected non-small cell lung cancer.
    Butkiewicz D; Rusin M; Sikora B; Lach A; Chorąży M
    Mol Biol Rep; 2011 Nov; 38(8):5231-41. PubMed ID: 21188533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of DNA repair gene polymorphisms on prognosis in inoperable non-small cell lung cancer patients treated with radiotherapy and platinum-based chemotherapy.
    Butkiewicz D; Drosik A; Suwiński R; Krześniak M; Rusin M; Kosarewicz A; Rachtan J; Matuszczyk I; Gawkowska-Suwińska M
    Int J Cancer; 2012 Oct; 131(7):E1100-8. PubMed ID: 22511383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.
    López-Cima MF; González-Arriaga P; García-Castro L; Pascual T; Marrón MG; Puente XS; Tardón A
    BMC Cancer; 2007 Aug; 7():162. PubMed ID: 17705814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer.
    Popanda O; Schattenberg T; Phong CT; Butkiewicz D; Risch A; Edler L; Kayser K; Dienemann H; Schulz V; Drings P; Bartsch H; Schmezer P
    Carcinogenesis; 2004 Dec; 25(12):2433-41. PubMed ID: 15333465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of polymorphisms in DNA repair genes and MDR1 gene with chemotherapy response and survival of non-small cell lung cancer.
    Du Y; Su T; Zhao L; Tan X; Chang W; Zhang H; Cao G
    PLoS One; 2014; 9(6):e99843. PubMed ID: 24933103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA Repair Gene Polymorphisms in Relation to Non-Small Cell Lung Cancer Survival.
    Su Y; Zhang H; Xu F; Kong J; Yu H; Qian B
    Cell Physiol Biochem; 2015; 36(4):1419-29. PubMed ID: 26159902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.
    Gao WM; Romkes M; Day RD; Siegfried JM; Luketich JD; Mady HH; Melhem MF; Keohavong P
    Carcinogenesis; 2003 Oct; 24(10):1671-6. PubMed ID: 12844488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms in DNA repair genes and risk of lung cancer.
    Butkiewicz D; Rusin M; Enewold L; Shields PG; Chorazy M; Harris CC
    Carcinogenesis; 2001 Apr; 22(4):593-7. PubMed ID: 11285194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer.
    Zienolddiny S; Campa D; Lind H; Ryberg D; Skaug V; Stangeland L; Phillips DH; Canzian F; Haugen A
    Carcinogenesis; 2006 Mar; 27(3):560-7. PubMed ID: 16195237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India.
    Sreeja L; Syamala VS; Syamala V; Hariharan S; Raveendran PB; Vijayalekshmi RV; Madhavan J; Ankathil R
    J Cancer Res Clin Oncol; 2008 Jun; 134(6):645-52. PubMed ID: 17952468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk.
    Qian B; Zhang H; Zhang L; Zhou X; Yu H; Chen K
    Lung Cancer; 2011 Aug; 73(2):138-46. PubMed ID: 21195504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk.
    De Ruyck K; Szaumkessel M; De Rudder I; Dehoorne A; Vral A; Claes K; Velghe A; Van Meerbeeck J; Thierens H
    Mutat Res; 2007 Jul; 631(2):101-10. PubMed ID: 17531525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of polymorphisms in the XRCC1, XRCC3, and XPG genes on clinical outcomes of platinum-based chemotherapy for treatment of non-small cell lung cancer.
    Jin ZY; Zhao XT; Zhang LN; Wang Y; Yue WT; Xu SF
    Genet Mol Res; 2014 Mar; 13(3):7617-25. PubMed ID: 24737519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms in DNA repair genes as modulators of Hodgkin disease risk.
    El-Zein R; Monroy CM; Etzel CJ; Cortes AC; Xing Y; Collier AL; Strom SS
    Cancer; 2009 Apr; 115(8):1651-9. PubMed ID: 19280628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population.
    Improta G; Sgambato A; Bianchino G; Zupa A; Grieco V; La Torre G; Traficante A; Cittadini A
    Anticancer Res; 2008; 28(5B):2941-6. PubMed ID: 19031937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy.
    Gurubhagavatula S; Liu G; Park S; Zhou W; Su L; Wain JC; Lynch TJ; Neuberg DS; Christiani DC
    J Clin Oncol; 2004 Jul; 22(13):2594-601. PubMed ID: 15173214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The codon 399 Arg/Gln XRCC1 polymorphism is associated with lung cancer in Indians.
    Natukula K; Jamil K; Pingali UR; Attili VS; Madireddy UR
    Asian Pac J Cancer Prev; 2013; 14(9):5275-9. PubMed ID: 24175813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in the DNA repair genes XRCC1, APEX1, XRCC3 and NBS1, and the risk for lung cancer in never- and ever-smokers.
    Ryk C; Kumar R; Thirumaran RK; Hou SM
    Lung Cancer; 2006 Dec; 54(3):285-92. PubMed ID: 17034901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APEX1 Asp148Glu gene polymorphism is a risk factor for lung cancer in relation to smoking in Japanese.
    Osawa K; Miyaishi A; Uchino K; Osawa Y; Inoue N; Nakarai C; Tsutou A; Kido Y; Yoshimura M; Tsubota N; Takahashi J
    Asian Pac J Cancer Prev; 2010; 11(5):1181-6. PubMed ID: 21198260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. XRCC3 Thr241Met and XPD Lys751Gln gene polymorphisms and risk of clear cell renal cell carcinoma.
    Loghin A; Bănescu C; Nechifor-Boila A; Chibelean C; Orsolya M; Nechifor-Boila A; Tripon F; Voidazan S; Borda A
    Cancer Biomark; 2016; 16(2):211-7. PubMed ID: 26682510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.